• 동의생리병리학회지
• /
• 제38권1호
• /
• pp.1-9
• /
• 2024

Cognitive reserve (CR) is a concept that can explain the discrepancies between the pathologic burden of the disease and clinical manifestations. It refers to the individual susceptibility to age-related brain changes and pathologies related to Alzheimer's disease, thus recognized as a factor affecting the trajectories of the disease. The purpose of this study was to explore the current states of clinical studies on neural substrates of CR in Alzheimer's disease using functional magnetic resonance imaging. We searched for clinical studies on CR using fMRI in the Pubmed, Cochrane library, RISS, KISS and ScienceON on August 14, 2023. Once the online search was finished, studies were selected manually by the inclusion criteria. Finally, we analyzed the characteristics of selected articles and reviewed the neural substrates of CR. Total thirty-four studies were included in this study. As surrogate markers of CR, not only education and occupational complexity, but also composite score and questionnaire-based method, which cover various areas of life, were mainly used. The most utilized methods in resting-state fMRI were independent component analysis, seed-based analysis, and graph theory analysis. Through the analysis, we demonstrated that neuroimaging techniques could capture the neural substrates associated with cognitive reserve. Moreover, functional connectivity of brain regions centered on prefrontal and parietal cortex and network areas such as default mode network showed a significant correlation with CR, which indicated a significant association with cognitive performance. CR may induce differential effects according to the disease status. We hope that this perspective on cognitive reserve would be helpful when conducting clinical researches on the mechanisms of traditional Korean medicine for Alzheimer's disease in the future.

• Asian Pacific Journal of Cancer Prevention
• /
• 제13권12호
• /
• pp.6227-6232
• /
• 2012

Interleukin-4 receptor (IL-4R) gene single nucleotide polymorphisms (SNPs) are implicated in cancer development. However, results from the published reports have remained inconclusive. The objective of this study was to conduct a meta-analysis investigating the association between polymorphisms in IL-4R gene and cancer risk. Pubmed, EMBASE and China National Knowledge Infrastructure (CNKI) were searched for case-control studies published up to October 30, 2012 that investigated IL-4R polymorphisms and cancer risk. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to evaluate the strength of any associations. Three IL-4R polymorphisms (Q576R, rs1801275; I75V, rs1805010; S503P, rs1805015) in 21 case-control studies were analyzed. Our meta-analysis indicated that these three polymorphisms are not associated with cancer risk when all studies were pooled together. In the subgroup analysis by tumor site, the results showed that Q576R G allele carriers were associated with a significantly decreased cervical cancer risk (recessive model: OR = 0.77, 95%CI = 0.60-0.98; homozygote comparison: OR = 0.76, 95%CI = 0.58-0.98). I75V G allele carriers were associated with a decreased risk of renal cancer (dominant model = 0.71, 95%CI = 0.57-0.89, heterozygote comparison: OR = 0.69, 95%CI = 0.55-0.87). When stratified by ethnicity, Q576R G allele carriers were associated with a decreased cancer risk in Caucasians (dominant model: OR = 0.90, 95%CI = 0.83-0.98; heterozygote comparison: OR = 0.89, 95%CI = 0.82-0.98). I75V G allele carriers were associated with a decreased cancer risk in Asians (heterozygote comparison: OR = 0.76, 95%CI = 0.62-0.94). S503P C allele carriers were also associated with a decreased cancer risk in Asians (CC VS TT: OR = 0.29, 95%CI = 0.08-0.99). Our results suggest that Q576R, I75V and S503P may be associated with a decreased cancer risk for certain types of cancers and in some specific ethnic groups. Future case-control studies with large sample size are needed to evaluate these associations in detail.

• 대한감각통합치료학회지
• /
• 제21권2호
• /
• pp.69-83
• /
• 2023

목적 : 본 연구는 수면장애 아동을 대상으로 사회적 이야기(social story)를 적용한 연구를 대상으로 중재효과를 체계적으로 고찰하고자 하였다. 연구방법 : 본 연구는 2001년에서 2022년까지 데이터베이스 Scopus, ScienceDirect, psycArticles, Pubmed에 게재된 문헌들을 대상으로 하였다. 검색어는 'social story' OR 'social stories' AND 'sleep' OR 'sleep disorders' OR 'sleep wake disorder bedtimes' OR 'sleep initiation' and 'maintenance disorders' OR 'sleep wake disorder' OR 'sleep arousal disorder'을 사용하였다. 선정 기준에 따라 최종적으로 6편의 실험연구를 선정하여 분석을 실시하였다. 결과 : 분석 대상 문헌은 무작위 대조 실험연구는 2편, 개별 실험연구가 3편, 사례연구가 1편이었다. 대상자는 진단별로는 자폐스펙트럼 아동, 연령별로는 학령기와 청소년기가 가장 많았다. 중재유형은 사회적 이야기와 다른 중재를 함께 포함한 복합중재가 많았고, 중재 기간은 1일부터 40일 이상으로 다양하였다. 중재 효과로는 수면의 질에 긍정적인 효과를 보였으며, 그중에서도 야간 각성(night walking), 수면 시작 지연(sleep onset delay), 수면 불안(sleep anxiety)이 개선되었다. 사회적 이야기의 효과를 평가하는 도구로는 표준화된 평가에서는 아동 수면 습관 설문지(children's sleep habits questionnaire)와 아동 행동 체크리스트(child behavior checklist)를 가장 많이 사용하였고, 비표준화된 평가로는 인터뷰(interview), 수면일기 (Sleep diary)를 사용한 연구가 많았다. 결론 : 본 연구는 수면장애가 있는 아동 및 청소년에게 사회적 이야기를 적용함으로써 임상에서 적용할 수 있는 수면 중재 방향을 모색하는 것에 의의가 있다. 사회적 이야기의 중재 효과로는 야간 각성(night wakings), 수면 시작 지연(sleep onset delay), 수면 불안(sleep anxiety) 영역이 개선된 연구들이 큰 비중을 차지하였다. 수면의 질의 세부 효과 영역은 대부분의 연구에서 중재 전후 유의한 개선을 나타냈으며, 본 연구에서 분석한 6편의 연구에서는 추적검사를 통해서 중재 효과에 대한 지속을 확인할 수 있었다. 따라서 본 연구는 사회적 이야기(social story)를 적용한 수면장애 아동의 중재 효과, 결과 평가 도구, 중재 기간을 제시함으로써 수면장애 아동을 대상으로 사회적 이야기(social story)를 임상에서 적용할 때 도움이 될 것으로 판단된다.